- Home
- UNTY vs REPL Comparison
UNTY vs REPL Comparison
Compare UNTY & REPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UNTY
- REPL
- Stock Information
- Founded
- UNTY 1991
- REPL 2015
- Country
- UNTY United States
- REPL United States
- Employees
- UNTY N/A
- REPL N/A
- Industry
- UNTY Major Banks
- REPL Biotechnology: Pharmaceutical Preparations
- Sector
- UNTY Finance
- REPL Health Care
- Exchange
- UNTY Nasdaq
- REPL Nasdaq
- Market Cap
- UNTY 507.4M
- REPL 547.0M
- IPO Year
- UNTY 1997
- REPL 2018
- Fundamental
- Price
- UNTY $45.12
- REPL $8.43
- Analyst Decision
- UNTY Buy
- REPL Buy
- Analyst Count
- UNTY 3
- REPL 9
- Target Price
- UNTY $59.67
- REPL $12.00
- AVG Volume (30 Days)
- UNTY 41.6K
- REPL 8.6M
- Earning Date
- UNTY 10-14-2025
- REPL 11-06-2025
- Dividend Yield
- UNTY 1.31%
- REPL N/A
- EPS Growth
- UNTY 35.12
- REPL N/A
- EPS
- UNTY 5.27
- REPL N/A
- Revenue
- UNTY $121,970,000.00
- REPL N/A
- Revenue This Year
- UNTY $24.41
- REPL N/A
- Revenue Next Year
- UNTY $11.16
- REPL N/A
- P/E Ratio
- UNTY $8.71
- REPL N/A
- Revenue Growth
- UNTY 20.98
- REPL N/A
- 52 Week Low
- UNTY $36.65
- REPL $2.68
- 52 Week High
- UNTY $54.64
- REPL $17.00
- Technical
- Relative Strength Index (RSI)
- UNTY 36.82
- REPL 57.35
- Support Level
- UNTY $44.34
- REPL $8.26
- Resistance Level
- UNTY $49.26
- REPL $10.85
- Average True Range (ATR)
- UNTY 1.20
- REPL 0.83
- MACD
- UNTY -0.17
- REPL -0.06
- Stochastic Oscillator
- UNTY 14.01
- REPL 22.94
About UNTY Unity Bancorp Inc.
Unity Bancorp Inc is a bank holding company that serves as a holding company for Unity Bank. It conducts a traditional and community-oriented commercial banking business and offers services, including personal and business checking accounts, time deposits, money market accounts, regular savings accounts, and others. The company structures its specific services and charges in a manner designed to attract the business of small and medium-sized businesses and professional communities, as well as individuals residing, working, and shopping in its service area. The company engages in a wide range of lending activities and offers commercial, Small Business Administration, consumer, mortgage, home equity, and personal loans.
About REPL Replimune Group Inc.
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3. The company operates in USA and UK, majority of revenue from USA.